Clinical Trials Directory

Trials / Completed

CompletedNCT04380389

Accuracy of ScanWatch Pulse Oximeter With Profound Hypoxia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Withings · Industry
Sex
All
Age
18 Years – 49 Years
Healthy volunteers
Accepted

Summary

Performance testing of pulse oximeters. The protocol involves brief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained. The blood sample is analyzed for oxygen saturation with a gold standard bench CO-oximeter. This protocol is aligned with the latest ISO and FDA guidance documents for pulse oximeter testing.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESThypoxiaBrief stable arterial oxygen desaturation in healthy volunteers and sampling arterial blood when a stable level of hypoxia has been attained.

Timeline

Start date
2020-03-11
Primary completion
2020-03-12
Completion
2020-03-12
First posted
2020-05-08
Last updated
2020-05-08

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04380389. Inclusion in this directory is not an endorsement.

Accuracy of ScanWatch Pulse Oximeter With Profound Hypoxia (NCT04380389) · Clinical Trials Directory